Celanese Reports Strong Q1 Results, Raises Full-Year Free Cash Flow Target, and Outlines Deleveraging Progress
Summary
Celanese Corporation reported Q1 2026 adjusted EPS of $0.85 and positive free cash flow for the first time since 2022, leading to an increased full-year free cash flow target and significant deleveraging progress.
Key Events
-
Strong Q1 Performance
Reported adjusted EPS of $0.85, at the upper end of expectations, and achieved positive free cash flow ($3 million) for the first time since 2022.
-
Increased Full-Year Free Cash Flow Target
Raised the 2026 free cash flow target to $700-$800 million, reflecting improved earnings and operational efficiency.
-
Aggressive Deleveraging Plan
Targeting a reduction in net debt to operating EBITDA ratio to approximately 4.8x by year-end 2026, a substantial improvement from ~6x at the end of 2025.
-
Positive Q2 and Second Half Guidance
Provided Q2 adjusted EPS guidance of $2.00-$2.40 and anticipated second-half adjusted EPS of approximately $3.00, indicating continued operational strength.
Analysis
This 8-K furnishes the official Q1 2026 financial results and forward guidance, marking a significant positive shift from the company's previous 10-K which warned of potential debt covenant non-compliance. The company delivered adjusted EPS at the high end of expectations and achieved positive free cash flow in Q1, a key milestone. Management raised its full-year 2026 free cash flow target to $700-$800 million and outlined a clear path to reduce net debt to operating EBITDA to approximately 4.8x by year-end. These results, coupled with ongoing operational restructuring and cost-saving initiatives, demonstrate strong execution and improved financial health, providing a more stable outlook for investors. The stock is currently trading near its 52-week high, and this positive report could reinforce investor confidence.
At the time of this filing, CE was trading at $69.01 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $35.13 to $70.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.